PHARMACOGENOMICS OF OSTEOPOROTIC FRACTURES.
Although scarce data are available, interesting opportunities are open for a better understanding of the pharmacogenetics of osteoporosis and osteoporotic fractures. They include the reanalysis of data already available from epidemiological studies and clinical trials, … Leer más